Hyderabad, Jan. 14 -- : Dr. Reddy's Laboratories on Wednesday announced the first-to-market U.S. launch of Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC), the generic equivalent of Extra-Strength Pataday(R) Once-Daily Relief, following approval by the U.S. Food and Drug Administration.
The over-the-counter (OTC) antihistamine eye drop is indicated for the temporary relief of itchy eyes caused by pollen, ragweed, grass, animal hair, and dander, the Hyderabad based pharma Giant said in a release. The product is available in a 2.5 mL bottle.
With this launch, Dr. Reddy's expands its OTC eye-care portfolio, which already includes olopatadine ophthalmic solutions in 0.1% and 0.2% strengths.
Published by HT Digital Content Servi...